We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMBS icon
1551
Rambus
RMBS
$11B
$322K ﹤0.01%
+3,505
New +$345K
EME icon
1552
Emcor
EME
$36B
$321K ﹤0.01%
+525
New +$340K
TNDM icon
1553
Tandem Diabetes Care
TNDM
$1.56B
$321K ﹤0.01%
14,590
-128,265
-90% -$2.31M
SLDE
1554
Slide Insurance Holdings
SLDE
$2.47B
$320K ﹤0.01%
16,434
-5,060
-24% -$84.4K
JBTM
1555
JBT Marel
JBTM
$6.39B
$319K ﹤0.01%
2,119
-135,504
-98% -$19.1M
RC
1556
Ready Capital
RC
$308M
$319K ﹤0.01%
+146,447
New +$410K
BANF icon
1557
BancFirst
BANF
$3.8B
$319K ﹤0.01%
+3,010
New +$341K
UFPI icon
1558
UFP Industries
UFPI
$5.19B
$318K ﹤0.01%
3,495
-46,312
-93% -$4.24M
PSKY
1559
Paramount Skydance Corp
PSKY
$10.3B
$317K ﹤0.01%
23,660
+11,885
+101% +$186K
FOXA icon
1560
Fox Class A
FOXA
$26.9B
$316K ﹤0.01%
4,323
-56,653
-93% -$3.7M
OVID icon
1561
Ovid Therapeutics
OVID
$491M
$314K ﹤0.01%
192,496
-690,658
-78% -$1.06M
TGS icon
1562
Transportadora de Gas del Sur
TGS
$4.33B
$313K ﹤0.01%
+10,082
New +$285K
NTWO
1563
Newbury Street II Acquisition Corp
NTWO
$259M
$313K ﹤0.01%
30,049
-9,923
-25% -$103K
JACS
1564
Jackson Acquisition Co II
JACS
$317M
$312K ﹤0.01%
29,982
LATAU
1565
Galata Acquisition Corp. II Units
LATAU
$312K ﹤0.01%
30,993
+9,293
+43% +$93.5K
STX icon
1566
Seagate
STX
$184B
$312K ﹤0.01%
1,132
-44,642
-98% -$11.6M
CPB icon
1567
Campbell Soup
CPB
$6.87B
$310K ﹤0.01%
11,114
-281,643
-96% -$8.47M
TBPH icon
1568
Theravance Biopharma
TBPH
$877M
$310K ﹤0.01%
+16,555
New +$275K
BFLY icon
1569
Butterfly Network
BFLY
$2.35B
$309K ﹤0.01%
81,320
-362,791
-82% -$987K
CVX icon
1570
Chevron
CVX
$366B
$308K ﹤0.01%
2,019
-69,031
-97% -$10.5M
GPN icon
1571
Global Payments
GPN
$22.8B
$307K ﹤0.01%
3,965
-35,179
-90% -$2.83M
MOG.A icon
1572
Moog Inc Class A
MOG.A
$12.8B
$305K ﹤0.01%
1,252
-8,953
-88% -$1.97M
RNGTU
1573
Range Capital Acquisition Corp II Units
RNGTU
$212M
$303K ﹤0.01%
+29,657
New +$302K
SO icon
1574
Southern Company
SO
$107B
$301K ﹤0.01%
3,454
-68,069
-95% -$6.21M
FIZZ icon
1575
National Beverage
FIZZ
$3.01B
$299K ﹤0.01%
+9,362
New +$322K

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.